Replies to post #51 on BiondVax Pharmaceuticals Ltd (BVXV)

[midastouch017]

Like getting a loan without interest

LOL, not quite so, but an interesting comparison
nevertheless.

:-) :-) :-)

The PR says:

The non-dilutive grants are repayable from royalties generated from future sales of BiondVax's vaccine, once
available on the market.

Of course i have no idea of the details however
there is an agreement which enables NATI to
provide funds in return to getting royalties.
Naturally if the vaccine proves a flop, NATI gets
absolutely nothing in return.

If however the vaccine does generate income, the royalties
are in % of sales for a set amount of (quite many)
years, thus enabling NATI to assist/invest in other
potential projects!